employer glp-1 coverage news How Employers Can Manage Costs in Their Health Plans Employers Grapple with Claims Costs
Description
Expert guidance on safety, managing side effects, & preventing post-surgery diarrhoea.
Walk in to our James Island or North Charleston clinic, no appointment needed.
| When coupled with wraparound lifestyle support, 63% of Omada members maintained or continued to lose weight 12 months after discontinuing GLP-1s.
Learn which measurements matter most, how to document side effects, and which apps or methods simplify tracking for better diabetes and weight management outcomes.
Een nieuwe studie, die onlangs is gepubliceerd in JAMA Network Open, suggereert dat GLP-1 (glucagon-like peptide-1) receptoragonisten, die momenteel goedgekeurd zijn voor de behandeling van diabetes en obesitas, mogelijk een bijkomend voordeel hebben: ze kunnen het risico op bepaalde met obesitas geassocieerde kankers (obesity associated cancers, OACs) verminderen
